Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

YOD1 increases the amount of TGFB. 2 / 2

| 2

➶

reach

"The results of our study have shown that silencing of YOD1 by RNAi in HOK cells inhibits protein level of phosphor-Smad2/3 which may be associated with inhibition of TGF-β3 expression by YOD1 siRNA.Our data suggest that YOD1 siRNA will reduce the expression levels of TGF-β3 and phospho-Smad2/3."

30345304

➶

reach

"Furthermore, we have found that YOD1 siRNA decreases the mRNA levels of TGF-β3 and protein levels of phosphor-Smad2/3."

30345304

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...